DefenCath® (taurolidine and heparin) catheter lock solution is indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients.

Events

 Click to Download the Latest Investor Presentation

Upcoming Events

Past Events

CorMedix Inc. to Report Fourth Quarter 2022 Financial Results and Provide a Corporate Update
March 30 – 8:30AM ET, 2022
Click Here for Webcast
Domestic:                     877-423-9813
International:                201-689-8573
Conference ID:          13736467

CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update
November 10 – 8:30AM ET, 2022
Click Here for Webcast
Domestic:                     877-423-9813
International:                201-689-8573
Conference ID:             13733378

CorMedix Inc. to Report Second Quarter 2022 Financial Results and Provide a Corporate Update
August 11 – 8:30AM ET, 2022
Click Here for Webcast
Domestic:                     877-423-9813
International:                201-689-8573
Conference ID:            13730940

CorMedix Inc. to Report First Quarter 2022 Financial Results and Provide a Corporate Update
May 12 – 4:30pm ET, 2022
Click Here for Webcast
Domestic:                     877-423-9813
International:                201-689-8573
Conference ID:             13729290

CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
Tuesday, April 12th – 11:00 am ET
Click Here for Webcast

CorMedix Inc. to Report Fourth Quarter 2021 Financial Results and Provide a Corporate Update
March 29 – 4:30pm ET, 2021
Click Here for Webcast
Domestic:                     877-423-9813
International:                201-689-8573
Conference ID:            13727363

CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update
November 9 – 4:30pm ET, 2021
Click Here for Webcast
Domestic:                     877-423-9813
International:                201-689-8573
Conference ID:             13723602

CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update
August 12 – 4:30pm ET, 2021
Click Here for Webcast
Domestic:                     877-423-9813
International:                201-689-8573
Conference ID:             13721575

CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference
Date:               Wednesday, June 16
Time:              12:00 pm Eastern Time
Webcast:         https://wsw.com/webcast/jmp49/crmd/1671800

CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference
Date:               Friday, June 4
Time:              11:30 am Eastern Time
Webcast:         https://wsw.com/webcast/jeff174/crmd/1840266

CorMedix Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update
May 13 – 4:30pm ET, 2021
Click Here for Webcast
Domestic:                     877-423-9813
International:                201-689-8573
Conference ID:             13718937

CorMedix Inc. to Participate at the 7th Annual Truist Securities Life Sciences Summit
May 4th – 5th 2021

CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference
Wednesday, April 14th – 4:30 pm ET
Click Here for Webcast

CorMedix Inc. to Report Fourth Quarter 2020 Financial Results and Provide a Corporate Update
March 30 – 4:30pm ET, 2021
Click Here for Webcast
Domestic:                       877-423-9813
International:                 201-698-8573
Conference ID:               13715664

CorMedix Inc. to Host Regulatory Update Conference Call
March 9 – 8:30am ET, 2021
Click Here for Webcast
Domestic:                     877-423-9813
International:               201-689-8573
Conference ID:            13717520

CorMedix Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update
November 5 – 4:30pm ET, 2020
Click Here for Webcast
Domestic:                       877-917-9975
International:                212-231-2901
Conference ID:              21971218

CorMedix Inc. To Present at the H.C Wainwright 22nd Annual Global Investment Conference
September 14, 2020 – 11:00 am ET
Click Here for Webcast         Click Here for Presentation

CorMedix Inc. to Report Second Quarter 2020 Financial Results and Provide a Corporate Update
August 10 – 4:30pm ET, 2020
Click Here for Webcast
Domestic:                       877-423-9813
International:                201-698-8573
Conference ID:              13707638

CorMedix Inc. to Report First Quarter 2020 Financial Results and Provide a Corporate Update
May 11 – 4:30pm ET, 2020
Click Here for Webcast
Domestic:                      800-949-2175
International:                646-828-8144
Conference ID:              3381536

CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections (CRBSIs), and the Potential for Neutrolin®
May 19 – 12:00pm ET, 2020
Click Here for Webcast
Domestic:                                    877-423-9813
International:                              201-689-8573
Conference ID:                             13703060

CorMedix Inc. to Report Fourth Quarter 2019 Financial Results and Provide a Corporate Update
March 16 – 4:30pm ET, 2020
Click Here for Webcast

CorMedix Inc. to Report Third Quarter 2019 Financial Results and Provide a Corporate Update
November 14 – 4:30pm ET, 2019
Click below to listen to call audio:


CorMedix Inc. To Present at the Cantor 2019 Global Healthcare Conference
October 3, 2019 – 3:35 pm ET
Click Here for webcast

Rodman & Renshaw Global Investor Conference 2019
September 9, 2019 – 9:10 a.m. ET
Click Here for Webcast

CorMedix Inc. to Report Second Quarter 2019 Financial Results and Provide a Corporate Update
August 13 – 4:30pm ET, 2019
Click Here for Webcast

CorMedix Inc. to present at the Annual B. Riley FBR Institutional Investor Conference
May 22, 2019  – 11:00 a.m PT  –  2:00p.m ET
Click Here for Webcast

CorMedix Inc. to Report First Quarter 2019 Financial Results and Provide a Corporate Update
May 13 – 4:30pm ET, 2019
Click Here for Webcast

CorMedix Inc. to present at Oppenheimer & Co. Inc. 29th Annual Healthcare Conference
March 19-20, 2019
Click Here for Webcast

CorMedix Inc. to present at 31st Annual ROTH Conference
March 18, 2019 – 2:00pm PT
Click Here for Webcast

CorMedix Inc. Fourth Quarter 2018 Results Conference Call
March 14, 2018 – 4:30 pm ET
Click to Listen to Webcast

Conference call: CorMedix inc. Lock-It -100 Topline Data Discussion
January 17, 2019– 4:30 pm ET
Click to Listen to Webcast

CorMedix Inc. Third Quarter 2018 Results Conference Call
November 14, 2018 – 4:30 pm ET
Click to Listen to Webcast

Rodman & Renshaw Global Investor Conference 2018
September 6, 2018 – 4:40p.m. ET
Click to Listen to Webcast

CorMedix Inc. Second Quarter 2018 Results Conference Call
August 14, 2018 – 4:30 pm ET
Click to Listen to Webcast

CorMedix Inc. First Quarter 2018 Results Conference Call
May 15, 2018 – 4:30pm ET

Kidney Week 2017
October 31-November 5, 2017

2nd Annual Gulf Congress of Clinical Microbiology and Infectious Diseases
November 1-4, 2017
Kingdom of Bahrain

The MicroCap Conference
October 5, 2017
The Essex House, New York

Anti-Infectives Rx
September 19, 2017
Harvard Medical School; Joseph B. Martin Conference Center

Rodman & Renshaw Global Investor Conference 2017
September 11, 2017 – 3:50 p.m. ET
Click to Listen to Webcast

CorMedix Inc. Second Quarter 2017 Results Conference Call
August 9, 2017 – 4:30 p.m. ET

Reconvened Special Meeting of Stockholders
August 8, 2017, at 11:00 a.m. Eastern time
1430 U.S. Highway 206, Suite 200
Bedminster, New Jersey

CorMedix Inc. R&D Day 2017
July 12, 2017 – 8:30am ET
Click Here for the Webcast

Special Meeting of Stockholders
July 31, 2017, at 11:00 a.m. Eastern time
545 U.S. Highway 206, First Floor Conference Room
Bedminster, New Jersey

CorMedix Inc. Annual Meeting of Stockholders 2017
June 12, 2017, at 11:00 a.m. Eastern time

545 U.S. Highway 206, First Floor Conference Room
Bedminster, New Jersey

CorMedix Inc. First Quarter 2017 Results Conference call
May 10, 2017

CorMedix Inc. Fourth Quarter and Full Year 2016 Results Conference call
March 17, 2017


Biotech Showcase 2017
January 10, 2017
San Francisco, California